Aging, female sex, migration, elevated HDL-C, and inflammation are associated with prevalence of metabolic syndrome among African bank employees

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 495-503

  Gombet, Thierry ^a   Longo Mbenza, Benjamin ^b   Ellenga Mbolla, Bertrand ^a   Ikama, Meo Stephane ^a   Mokondjimobe, Etienne ^c   Kimbally Kaky, Gisele ^a   Nkoua, Jean Louis ^a  

^a University Hospital Center of Brazzaville   (Congo)

^b WALTER SISULU UNIVERSITY   (South Africa)

^c Laboratory of Biochemistry and Pharmacology   (Congo)

Author keywords

Atherosclerosis; Inflammation; Insulin resistance; Liver enzymes; Metabolic syndrome; Sub Saharan Africa

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; AGING; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BANK EMPLOYEE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EMPLOYEE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRANSAMINASEMIA; INFLAMMATION; INSULIN RESISTANCE; INTERNATIONAL DIABETES FEDERATION FOR CENTRAL AMERICA; INTERNATIONAL DIABETES FEDERATION FOR EUROPE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIGRATION; NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III CRITERIA; NEGRO; OBESITY; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RURAL URBAN MIGRATION; SEDENTARY LIFESTYLE; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION CRITERIA;

EID: 84877123291     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S29700     Document Type: Article

References (45)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular mortality in middle-aged men. JAMA. 2002;288(21):2709-2716.
2. Ford ES. Risks for all-cause mortality, cardiovascular, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769-1778.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-1428.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Educational Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
6. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
7. Enkhmaa B, Shiwaku K, Anuurad E, et al. Prevalence of the metabolic using the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATPIII) and the modified ATPIII definitions for Japanese and Mongolians. Clin Chim Acta. 2005;352(1-2):105-113.
8. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, et al. High prevalence of the metabolic syndrome in Mexico. Arch Med Res. 2004;35(1):76-81.
9. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Cardiology. 2004;97(2):57-61.
10. Kraja AT, Hunt SC, Pankow JS, et al. An evaluation of the metabolic syndrome in the HyperGen study. Nutr Med (Lond). 2005;2(1):17-25.
11. World Health Organization. Non-Communicable Diseases: A Strategy for the African Region. Harare, Zimbabwe: WHO Regional Office for Africa; 2000.
12. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-2753.
13. Makuyana D, Gomo Z, Munyombwe T, Matenga JA, Hakim JG. Metabolic syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus. Cent Afr J Med. 2004;50(3-4):24-29.
14. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease. Cardiovasc J S Afr. 2006;17(2):50-55.
15. Ker JA, Rheeder P, Van Tonder R. Frequency of the metabolic syndrome in screened South African corporate executives. Cardiovasc J S Afr. 2007;18(1):30-33.
16. Fezeu L, Balkau, Kengne AP, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: dentral obesity may be the key determinant. Atherosclerosis. 2007;193(1):70-76.
17. Kasiam Lasi On'kin JB, Longo-Mbenza B, Nge Okwe A, Kangola Kabangu N. Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo. Cardiovasc J Afr. 2007;18(5):300-307.
18. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc. 2005;97(4):557-563.
19. Schultz AB, Edington DW. The association between changes in metabolic syndrome and changes in cost in a workplace population. J Occup Environ Med. 2009;51(7):771-779.
20. Kawada T, Otsuka T, Inagaki H, Wakayama Y, Li Q, Katsumata M. Relationship between two indicators of coronary risk estimated by the Framingham Risk Score and the number of metabolic syndrome components in Japanese male manufacturing workers. Metab Relat Disord. 2009;7(5):335-340.
21. Schultz AB, Edington DW. Metabolic syndrome in a workplace: prevalence, co-morbidities, and economic impact. Metab Syndr Relat Disord. 2009;7(5):459-468.
22. Kawada T, Okada K, Amezawa M. Components of the metabolic syndrome and lifestyle factors in Japanese male workers. Metab Syndr Relat Disord. 2008;6(4):263-266.
23. Yoon J, Yi K, Oh J, Lee S. The relationship between metabolic syndrome and Korean cardiocerebrovascular risk assessment: for male researchers in a workplace. [Article in Korean]. J Prev Med Public Health. 2007;40(5):397-403.
24. Oberlinner C, Humpert PM, Nawroth PP, Zober A, Marcos M. Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample. Acta Diabetol. 2008;45(1):31-35.
25. No authors listed. Arterial hypertension. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1978;628:7-56.
26. Longo-Mbenza B, Nkoy Belila J, Vangu Ngoma D, Mbungu S. Prevalence and risk factors of arterial hypertension among urban Africans in workplace: the obsolete role of body mass index. Niger J Med. 2007;16(1):42-49.
27. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1007;157(1):79-85.
28. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442-443.
29. Santos AC, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diabetes Vasc Dis Res. 2007;4(4):320-327.
30. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351-375.
31. Skilton MK, Moulin P, Serusclat A, Nony P, Bonnet F. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis. 2007;190(2):416-422.
32. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutritional Examination Survey. JAMA. 2002;287(3):356-359.
33. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164(10):1066-1076.
34. Sibai AM, Obeid OA, Batal M, Adra N, Dit El Khoury DT, Hwalla N. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prev Control. 2008;3(2):83-90.
35. Ozsahin AK, Gokcel A, Sezgin N, et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab. 2004;17(4):230-234.
36. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003;26(6):1781-1785.
37. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003;61(1):29-37.
38. Villegas R, Xiang YB, Yang G, et al. Prevalence and determinants of metabolic syndrome according to the three definitions in middle-aged Chinese men. Metab Syndr Relat Disord. 2009;7(1):37-45.
39. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152(10):908-911.
40. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47.
41. Lee JS, Kawakubo K, Mori K, Akabayashi A. Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and women. Diabetes Vasc Dis Res. 2007;4(4):340-345.
42. Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N. Serum gamma-glutamyl transferase levels are associated with wetabolic syndrome in community-dwelling individuals. J Atheroscler Thromb. 2009;16(4):355-362.
43. Esteghamati A, Jamali A, Khalilzadeh O, et al. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol Metab Syndr. 2010;2:65.
44. Kasapoglu B, Turkay C, Bayram Y, Koca C. Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey. Indian J Med Res. 2010;132:56-61.
45. Oh HJ, Kim TH, Sohn YW, et al. Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the references range with metabolic syndrome and nonalcoholic fatty liver diseases. Korean J Hepatol. 2011;17(1):27-36.